Immunology
The National Institutes of Health launches the Symptom Science Center
The National Institutes of Health, National Institute of Nursing Research (NIH NINR) launched the Symptom Science Center on June 27th, 2019 at the NIH Campus in Bethesda, MD. This event, attended by over 500 individuals, marks a momentous occasion for both clinical and translational multidisciplinary research.  Discuss
Purchasing products: Experiences with scientists and suppliers
Recently, we asked over 900 members of the SAB to tell us more about how they purchase products through life science suppliers, and the factors that influence their selection of supplier.  Discuss
Customer service and technical support: From your perspective
Over 700 members of the SAB recently took part in a survey regarding their experiences with customer service and technical support through life science suppliers. We thought you’d like to know a little more about some of the results from this project, to understand how some of the research we conduct with your help ends up!  Discuss
UK Scientists Weigh In on Brexit and Laboratory Spending - Science Advisory Board Insights
The long road to a resolution of the Brexit situation appeared to be nearing an end earlier this year, with the deadline set for March 29 to finalize how Britain would exit the EU. A “hard” Brexit, the case if no EU-Britain agreement is reached, would remove Britain from the EU’s single market among other consequences. A “soft” exit would result in Britain remaining part of the single market, but not an EU member. With a government stalemate in Britain, the EU agreed to extend the deadline until October 31, though a deal may come sooner.  Discuss
The Promise of Targeted Therapeutics in Cancer Treatment
In 2018, the International Agency for Research on Cancer reported more than 18 million people were diagnosed with cancer. Between 40 and 45 million people worldwide are living with cancer and nearly 9.6 million people die. Cancer deaths occur in about 50% of people who develop cancer in developed countries; this is in contrast to 80% death rate in cancer patients in underdeveloped countries. The numbers are staggering. But there is hope, as scientists around the globe work on developing new technologies, in the form of targeted therapies, to combat the incidence of cancer.  Discuss
The Intersection of Life Scientists and Social Media: A Revolution
How do your peers receive information online and how do they utilize social media as a means of learning new information and sharing content? These are just a few of the questions that our colleagues at BioInformatics Inc. explored in a recent report about digital marketing to life scientists.  Discuss
The “Two-Headed Monster”: Vendors Tackle Antibody Validation
The Science Advisory Board examined the preferences of scientists regarding the purchase and use of antibodies, as well as customer trust, satisfaction, and "best-in-class" vendors in the sector. Respondents also made comments detailing their ideas on reproducible research using antibodies, the responsibilities of both vendors and researchers when it comes to using commercial antibodies, and much more.  Discuss
Analytical Instruments for Security: ‘To Detect and to Protect’
One important trend in the analytical instrumentation industry is the continued migration of laboratory technologies into non-laboratory settings. As instruments become more robust, easier to use and smaller, they have escaped the lab into the field in many different applications from environmental testing to point-of-care diagnostics. One critical use for instruments in the field is for security applications, protecting everyone from accidental and intentional threats to human health and public safety.  Discuss
High Performance Liquid Chromatography: A Growing Technology Driven by Pharmacology
Vaccines strengthen our immune systems by exposing white blood cells to disease-specific antigens. This builds a depot of memory T cells, so in the case of a full-on infection, our bodies can fight off malicious organisms with greater ease. Dr. Anthony S. Fauci, Director of the National Institute of Allergy and Infectious Diseases, has been working to develop an HIV vaccine for the past 30 years. This revolutionary medical tool would help reduce the dreadful effects of AIDS on the world population, for many years to come.  Discuss
Overlooked benefits of using polyclonal antibodies
The benefits of polyclonal antibodies as tools for assay-specific target discovery and detection are numerous. As the future of basic research, diagnostics and biomarker discovery is dependent on high-quality reproducible data, there is a need to understand the importance of and benefits of these valuable tools.  Discuss
Conferences
2nd Annual Cell Therapy Bioprocessing Conference
June 25-26
Boston, Massachusetts United States
BioProcess International Europe
July 13-16
Amsterdam, Noord-Holland Netherlands
Bioprocess International West
August 10-13
Santa Clara, California United States
General Discussion
Topic Replies / Views Last Update
https://academic.oup.com/ve/pages/coronavirus-evolution
by Michael
0 / 32 More than 3 days ago
by Michael
PopSci Hails Impossible Burger 2.0 as Most Important Engineering Innovation in 2019
by Mahesh Gupta
0 / 11 More than 3 days ago
by Mahesh Gupta
Engineered Bacteria Produces BeeFree Honey
by Mahesh Gupta
0 / 12 More than 3 days ago
by Mahesh Gupta
Consumers' Preference to Buy Unlabeled Produce Increases after Exposure to GMO-labeled Pro
by Mahesh Gupta
0 / 15 More than 3 days ago
by Mahesh Gupta
Super-precise new CRISPR tool could tackle a plethora of genetic diseases
by Mahesh Gupta
0 / 14 More than 3 days ago
by Mahesh Gupta
To see more posts from our community or to share a post of your own, go to our community's forum page.
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter